- MustGrow Biologics Corp. (MGRO) has provided an update on the progression of its mustard-derived crop protection and food preservation technology
- The company has signed several agreements with its global partners, Sumitomo Corporation, Bayer, Janssen PMP, and NexusBioAg
- The agreements are continuously working on developing MustGrow’s technology for various produce globally
- The technology is undergoing field trials, development work, and regulatory approval strategies
- MustGrow Biologics Corp. (MGRO) is unchanged, trading at $2.92 per share as of 12:41 p.m. ET
MustGrow Biologics (MGRO) has provided an update on the progression of its mustard-derived crop protection and food preservation technology.
The company has signed several agreements with its global partners, Sumitomo Corporation, Bayer, Janssen PMP, and NexusBioAg. The agreements made are continuously working on developing MustGrow’s technology for various produce throughout the Americas, Europe, Asia Pacific, Africa, and the Middle East,
Sumitomo Corporation has aided the company by generating data for soil bio-fumigation across multiple crops, evaluating application timing, methods, and dose rates. This has resulted in new country expansions and program extensions.
MustGrow stated that Bayer’s initial laboratory and greenhouse studies utilizing its mustard-derived technology have been promising. Subsequentially, the companies have new trials underway and further studies planned across Europe, Asia and Africa.
According to the company, NexusBioAg intends to trial the technology in a 2023 advantage program, which are wide-scale field trials conducted at the farmer level.
Harnessing MustGrow’s mustard-derived biological agent as a postharvest fruit and vegetable application, Janssen PMP has reported success in decay, fungal, and bacterial disease prevention efficacy. Next, Janssen PMP will focus on phytotoxicity, residues, application rates, application methods and dose timing.
MustGrow stated previously tested its organic mustard-based technology and outperformed leading synthetic chemical standards, which treat stored potatoes for fusarium dry rot disease and sprouting.
MustGrow Biologics Corp. (MGRO) is unchanged, trading at $2.92 per share as of 12:41 p.m. ET.
